2014
DOI: 10.1002/ana.24213
|View full text |Cite
|
Sign up to set email alerts
|

In vivo imaging of spinal cord atrophy in neuroinflammatory diseases

Abstract: Objective Spinal cord atrophy is prominent in chronic progressive neurologic diseases such as Human-T-cell lymphotropic virus type-1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS). Here we compared the spinal cord cross-sectional area (SCCSA) in HAM/TSP and MS to that of healthy volunteers (HV). Methods SCCSA and clinical disability scores were measured in 18 HAM/TSP, 4 asymptomatic carriers (AC) of HTLV-1, 18 MS, and 10 HV from a 3T MRI. SCCSA measured in p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
24
4
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
2
1

Relationship

2
8

Authors

Journals

citations
Cited by 36 publications
(32 citation statements)
references
References 33 publications
3
24
4
1
Order By: Relevance
“…Based on the demyelination scores, there is no significant change in the amount of myelin degeneration between the two mouse models, albeit the Rag1 mice show marginally higher scores. This correlates with other studies that have shown axonal loss and demyelination as clinical manifestations of HAM/TSP seen on histopathology (Liu et al 2014). In this study the data from the hu-mice has also corroborated previous findings that have reported stable PVL despite disease progression due to neurodegeneration (Liu et al 2014; Olavarria et al 2012).…”
Section: Discussionsupporting
confidence: 92%
“…Based on the demyelination scores, there is no significant change in the amount of myelin degeneration between the two mouse models, albeit the Rag1 mice show marginally higher scores. This correlates with other studies that have shown axonal loss and demyelination as clinical manifestations of HAM/TSP seen on histopathology (Liu et al 2014). In this study the data from the hu-mice has also corroborated previous findings that have reported stable PVL despite disease progression due to neurodegeneration (Liu et al 2014; Olavarria et al 2012).…”
Section: Discussionsupporting
confidence: 92%
“…T1-weighted spinal cord MRI was acquired on a 3T Prisma scanner (Siemens) using a three-dimensional (3D) gradient-echo sequence (TR=7.8 ms, TE=3 ms, flip angle=16°, 1 mm resolution, field of view: 256 mm (cervical), 320 mm (thoracic)) 3. Brain imaging was performed with a magnetisation-prepared rapid gradient-echo sequence (TR=2400 ms, TE=2.36 ms, TI=1000 ms, flip angle=8°, slice thickness=0.8 mm).…”
Section: Methodsmentioning
confidence: 99%
“…On the other hand, spinal cord damage parallels accumulation of motor disability [104, 105]. Optimized segmentation techniques have led to more and more reliable volumetric measures of these clinically meaningful structures [106, 107], and introducing them into the clinical practice seems to be the most reasonable approach, so far. Similarly, among the tractography-reconstructed WM fiber bundles [108], efforts should be spent to move into everyday clinical practice the imaging of a few clinically relevant tracts, such as the pyramidal tract and visual pathway – perhaps in conjunction with other imaging modalities such as optical coherence tomography [109113].…”
Section: Quantitative Mri: What Should Be Moved Into Clinical Practice?mentioning
confidence: 99%